2
|
Marcellin F, Brégigeon-Ronot S, Ramier C, Protopopescu C, Gilbert C, Di Beo V, Duvivier C, Bureau-Stoltmann M, Rosenthal E, Wittkop L, Salmon-Céron D, Carrieri P, Sogni P, Barré T, Salmon D, Wittkop L, Sogni P, Esterle L, Trimoulet P, Izopet J, Serfaty L, Paradis V, Spire B, Carrieri P, Valantin M, Pialoux G, Chas J, Zaegel-Faucher O, Barange K, Naqvi A, Rosenthal E, Bicart-See A, Bouchaud O, Gervais A, Lascoux-Combe C, Goujard C, Lacombe K, Duvivier C, Neau D, Morlat P, Bani-Sadr F, Meyer L, Boufassa F, Autran B, Roque A, Solas C, Fontaine H, Costagliola D, Piroth L, Simon A, Zucman D, Boué F, Miailhes P, Billaud E, Aumaître H, Rey D, Peytavin G, Petrov-Sanchez V, Levier A, Salmon D, Usubillaga R, Sogni P, Terris B, Tremeaux P, Katlama C, Valantin M, Stitou H, Simon A, Cacoub P, Nafissa S, Benhamou Y, Charlotte F, Fourati S, Poizot-Martin I, Zaegel O, Laroche H, Tamalet C, Pialoux G, Chas J, Callard P, Bendjaballah F, Amiel C, Le Pendeven C, Marchou B, Alric L, Barange K, Metivier S, Selves J, Larroquette F, Rosenthal E, Naqvi A, Rio V, Haudebourg J, Saint-Paul M, De Monte A, Giordanengo V, Partouche C, Bouchaud O, Martin A, Ziol M, Baazia Y, Iwaka-Bande V, Gerber A, Uzan M, Bicart-See A, Garipuy D, Ferro-Collados M, Selves J, Nicot F, Gervais A, Yazdanpanah Y, Adle-Biassette H, Alexandre G, Peytavin G, Lascoux-Combe C, Molina J, Bertheau P, Chaix M, Delaugerre C, Maylin S, Lacombe K, Bottero J, Krause J, Girard P, Wendum D, Cervera P, Adam J, Viala C, Vittecocq D, Goujard C, Quertainmont Y, Teicher E, Pallier C, Lortholary O, Duvivier C, Rouzaud C, Lourenco J, Touam F, Louisin C, Avettand-Fenoel V, Gardiennet E, Mélard A, Neau D, Ochoa A, Blanchard E, Castet-Lafarie S, Cazanave C, Malvy D, Dupon M, Dutronc H, Dauchy F, Lacaze-Buzy L, Desclaux A, Bioulac-Sage P, Trimoulet P, Reigadas S, Morlat P, Lacoste D, Bonnet F, Bernard N, Hessamfar M, Paccalin J, Martell C, Pertusa M, Vandenhende M, Mercié P, Malvy D, Pistone T, Receveur M, Méchain M, Duffau P, Rivoisy C, Faure I, Caldato S, Bioulac-Sage P, Trimoulet P, Reigadas S, Bellecave P, Tumiotto C, Pellegrin J, Viallard J, Lazzaro E, Greib C, Bioulac-Sage P, Trimoulet P, Reigadas S, Zucman D, Majerholc C, Brollo M, Farfour E, Boué F, Polo Devoto J, Kansau I, Chambrin V, Pignon C, Berroukeche L, Fior R, Martinez V, Abgrall S, Favier M, Deback C, Lévy Y, Dominguez S, Lelièvre J, Lascaux A, Melica G, Billaud E, Raffi F, Allavena C, Reliquet V, Boutoille D, Biron C, Lefebvre M, Hall N, Bouchez S, Rodallec A, Le Guen L, Hemon C, Miailhes P, Peyramond D, Chidiac C, Ader F, Biron F, Boibieux A, Cotte L, Ferry T, Perpoint T, Koffi J, Zoulim F, Bailly F, Lack P, Maynard M, Radenne S, Amiri M, Valour F, Koffi J, Zoulim F, Bailly F, Lack P, Maynard M, Radenne S, Augustin-Normand C, Scholtes C, Le-Thi T, Piroth L, Chavanet P, Duong Van Huyen M, Buisson M, Waldner-Combernoux A, Mahy S, Salmon Rousseau A, Martins C, Aumaître H, Galim S, Bani-Sadr F, Lambert D, Nguyen Y, Berger J, Hentzien M, Brodard V, Rey D, Partisani M, Batard M, Cheneau C, Priester M, Bernard-Henry C, de Mautort E, Fischer P, Gantner et S Fafi-Kremer P, Roustant F, Platterier P, Kmiec I, Traore L, Lepuil S, Parlier S, Sicart-Payssan V, Bedel E, Anriamiandrisoa S, Pomes C, Touam F, Louisin C, Mole M, Bolliot C, Catalan P, Mebarki M, Adda-Lievin A, Thilbaut P, Ousidhoum Y, Makhoukhi F, Braik O, Bayoud R, Gatey C, Pietri M, Le Baut V, Ben Rayana R, Bornarel D, Chesnel C, Beniken D, Pauchard M, Akel S, Caldato S, Lions C, Ivanova A, Ritleg AS, Debreux C, Chalal L, J.Zelie, Hue H, Soria A, Cavellec M, Breau S, Joulie A, Fisher P, Gohier S, Croisier-Bertin D, Ogoudjobi S, Brochier C, Thoirain-Galvan V, Le Cam M, Carrieri P, Chalouni M, Conte V, Dequae-Merchadou L, Desvallées M, Esterle L, Gilbert C, Gillet S, Guillochon Q, Khan C, Knight R, Marcellin F, Michel L, Mora M, Protopopescu C, Roux P, Spire B, Barré T, Ramier C, Sow A, Lions C, Di Beo V, Bureau M, Wittkop L. Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH). JHEP Rep 2022; 5:100614. [DOI: 10.1016/j.jhepr.2022.100614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/21/2022] [Revised: 10/06/2022] [Accepted: 10/07/2022] [Indexed: 11/06/2022] Open
|
4
|
Marcellin F, Di Beo V, Aumaitre H, Mora M, Wittkop L, Duvivier C, Protopopescu C, Lacombe K, Esterle L, Berenger C, Gilbert C, Bouchaud O, Poizot-Martin I, Sogni P, Salmon-Ceron D, Carrieri P, Wittkop L, Sogni P, Esterle L, Trimoulet P, Izopet J, Serfaty L, Paradis V, Spire B, Carrieri P, Valantin M, Pialoux G, Chas J, Poizot-Martin I, Barange K, Naqvi A, Rosenthal E, Bicart-See A, Bouchaud O, Gervais A, Lascoux-Combe C, Goujard C, Lacombe K, Duvivier C, Neau D, Morlat P, Bani-Sadr F, Meyer L, Boufassa F, Autran B, Roque A, Solas C, Fontaine H, Costagliola D, Piroth L, Simon A, Zucman D, Boué F, Miailhes P, Billaud E, Aumaître H, Rey D, Peytavin G, Petrov-Sanchez V, Lebrasseur-Longuet D, Salmon D, Usubillaga R, Sogni P, Terris B, Tremeaux P, Katlama C, Valantin M, Stitou H, Simon A, Cacoub P, Nafissa S, Benhamou Y, Charlotte F, Fourati S, Poizot-Martin I, Zaegel O, Laroche H, Tamalet C, Pialoux G, Chas J, Callard P, Bendjaballah F, Amiel C, Le Pendeven C, Marchou B, Alric L, Barange K, Metivier S, Selves J, Larroquette F, Rosenthal E, Naqvi A, Rio V, Haudebourg J, Saint-Paul M, De Monte A, Giordanengo V, Partouche C, Bouchaud O, Martin A, Ziol M, Baazia Y, Iwaka-Bande V, Gerber A, Uzan M, Bicart-See A, Garipuy D, Ferro-Collados M, Selves J, Nicot F, Gervais A, Yazdanpanah Y, Adle-Biassette H, Alexandre G, Peytavin G, Lascoux-Combe C, Molina J, Bertheau P, Chaix M, Delaugerre C, Maylin S, Lacombe K, Bottero J, Krause J, Girard P, Wendum D, Cervera P, Adam J, Viala C, Vittecocq D, Goujard C, Quertainmont Y, Teicher E, Pallier C, Lortholary O, Duvivier C, Rouzaud C, Lourenco J, Touam F, Louisin C, Avettand-Fenoel V, Gardiennet E, Mélard A, Neau D, Ochoa A, Blanchard E, Castet-Lafarie S, Cazanave C, Malvy D, Dupon M, Dutronc H, Dauchy F, Lacaze-Buzy L, Desclaux A, Bioulac-Sage P, Trimoulet P, Reigadas S, Morlat P, Lacoste D, Bonnet F, Bernard N, Hessamfar, J M, Paccalin F, Martell C, Pertusa M, Vandenhende M, Mercié P, Malvy D, Pistone T, Receveur M, Méchain M, Duau P, Rivoisy C, Faure I, Caldato S, Bioulac-Sage P, Trimoulet P, Reigadas S, Bellecave P, Tumiotto C, Pellegrin J, Viallard J, Lazzaro E, Greib C, Bioulac-Sage P, Trimoulet P, Reigadas S, Zucman D, Majerholc C, Brollo M, Farfour E, Boué F, Polo Devoto J, Kansau I, Chambrin V, Pignon C, Berroukeche L, Fior R, Martinez V, Abgrall S, Favier M, Deback C, Lévy Y, Dominguez S, Lelièvre J, Lascaux A, Melica G, Billaud E, Raffi F, Allavena C, Reliquet V, Boutoille D, Biron C, Lefebvre M, Hall N, Bouchez S, Rodallec A, Le Guen L, Hemon C, Miailhes P, Peyramond D, Chidiac C, Ader F, Biron F, Boibieux A, Cotte L, Ferry T, Perpoint T, Koffi J, Zoulim F, Bailly F, Lack P, Maynard M, Radenne S, Amiri M, Valour F, Koffi J, Zoulim F, Bailly F, Lack P, Maynard M, Radenne S, Augustin-Normand C, Scholtes C, Le-Thi T, Piroth L, Chavanet P, Duong Van Huyen M, Buisson M, Waldner-Combernoux A, Mahy S, Binois R, Simonet-Lann A, Croisier-Bertin D, Salmon Rousseau A, Martins C, Aumaître H, Galim S, Bani-Sadr F, Lambert D, Nguyen Y, Berger J, Hentzien M, Brodard V, Rey D, Partisani M, Batard M, Cheneau C, Priester M, Bernard-Henry C, de Mautort E, Gantner et S Fafi-Kremer P, Roustant F, Platterier P, Kmiec I, Traore L, Lepuil S, Parlier S, Sicart-Payssan V, Bedel E, Anriamiandrisoa S, Pomes C, Touam F, Louisin C, Mole M, Bolliot C, Catalan P, Mebarki M, Adda-Lievin A, Thilbaut P, Ousidhoum Y, Makhoukhi F, Braik O, Bayoud R, Gatey C, Pietri M, Le Baut V, Ben Rayana R, Bornarel D, Chesnel C, Beniken D, Pauchard M, Akel S, Caldato S, Lions C, Ivanova A, Ritleg AS, Debreux C, Chalal L, Zelie J, Hue H, Soria A, Cavellec M, Breau S, Joulie A, Fisher P, Gohier S, Croisier-Bertin D, Ogoudjobi S, Brochier C, Thoirain-Galvan V, Le Cam M, Carrieri P, Chalouni M, Conte V, Dequae-Merchadou L, Desvallees M, Esterle L, Gilbert C, Gillet S, Knight R, Lemboub T, Marcellin F, Michel L, Mora M, Protopopescu C, Roux P, Spire B, Tezkratt S, Barré T, Baudoin M, Santos M, Di Beo V, Nishimwe M, Wittkop L. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH). J Hepatol 2020; 72:588-591. [PMID: 31924411 DOI: 10.1016/j.jhep.2019.10.019] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/10/2019] [Revised: 10/17/2019] [Accepted: 10/25/2019] [Indexed: 01/26/2023]
Affiliation(s)
- Fabienne Marcellin
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France; ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France.
| | - Vincent Di Beo
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France; ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France
| | - Hugues Aumaitre
- Infectious and Tropical Disease Unit, Perpignan Hospital Center, Perpignan, France
| | - Marion Mora
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France; ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France
| | - Linda Wittkop
- Univ. Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, Team MORPH3EUS, UMR 1219, CIC-EC 1401, F-33000 Bordeaux, France; CHU de Bordeaux, Pole de santé publique, F-33000 Bordeaux, France
| | - Claudine Duvivier
- AP-HP-Necker Hospital, Infectious Diseases Department, Necker-Pasteur Infectiology Center, IHU Imagine, Université de Paris, INSERM, U1016, Institut Cochin, CNRS, UMR8104, Paris, France; Institut Pasteur, Medical Center of Institut Pasteur, Necker-Pasteur Infectiology Center, Paris, France
| | - Camelia Protopopescu
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France; ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France
| | - Karine Lacombe
- Infectious and Tropical Disease Unit, Paris Public Hospitals, Saint-Antoine Hospital, Paris, France; UMR S1136, Pierre Louis Epidemiology and Public Health Institute, Pierre and Marie Curie University, Paris, France
| | - Laure Esterle
- Univ. Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, Team MORPH3EUS, UMR 1219, CIC-EC 1401, F-33000 Bordeaux, France
| | - Cyril Berenger
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France; ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France
| | - Camille Gilbert
- Univ. Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, Team MORPH3EUS, UMR 1219, CIC-EC 1401, F-33000 Bordeaux, France
| | - Olivier Bouchaud
- Infectious and Tropical Disease Unit, Paris Publics Hospitals, Avicenne Hospital, Bobigny, France; Paris 13 Nord University, Bobigny, France
| | - Isabelle Poizot-Martin
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France; APHM Sainte-Marguerite, Clinical Immunohematology Unit, Aix Marseille University, Marseille, France
| | - Philippe Sogni
- Université Paris Descartes, Paris, France; INSERM U-1223, Institut Pasteur, Paris, France; Service d'Hépatologie, hôpital Cochin, Assistance Publique - Hôpitaux de Paris, France
| | - Dominique Salmon-Ceron
- Université Paris Descartes, Paris, France; Service Maladies infectieuses et tropicales, AP-HP, Hôpital Cochin, Paris, France
| | - Patrizia Carrieri
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France; ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Jacot W, Heudel PE, Fraisse J, Gourgou S, Guiu S, Dalenc F, Pistilli B, Campone M, Levy C, Debled M, Leheurteur M, Chaix M, Lefeuvre C, Goncalves A, Uwer L, Ferrero JM, Eymard JC, Petit T, Mouret-Reynier MA, Courtinard C, Cottu P, Robain M, Mailliez A. Abstract P6-14-02: Real-life activity of eribulin among metastatic breast cancer patients in the multicenter national observational ESME program. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p6-14-02] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: In 2014, UNICANCER (composed of 18 French Comprehensive Cancer Centers) launched the Epidemiological Strategy and Medical Economics (ESME) program to investigate real-world data in solid tumors. Real-world data give the opportunity to assess for the activity of specific drugs outside clinical trials. Eribulin is approved for pre-treated metastatic breast cancer (MBC). Marketing authorization has been granted in France in July 2012. However few data are available regarding its efficacy in real life. We evaluated eribulin use as second and third line of chemotherapy in MBC patients from the ESME database.
Methods: Data from all newly diagnosed MBC patients having initiated at least one treatment between Jan. 2008 and Dec. 2014 are included in the ESME database. Data were collected retrospectively using a clinical trial-like methodology. Primary endpoint was overall survival (OS), defined from the starting date of second or third line chemotherapy (eribulin versus other chemotherapy). Progression-free survival (PFS) was calculated as a secondary endpoint.
Results: Of 16,703 MBC patients included in the ESME database, 7,412 received at least 2 lines of chemotherapy: eribulin/other chemotherapy, total 1,966/5,446, second line 363/5,446, third line 654/2,669. Depending on second or third line chemotherapy use classification, median age was 59 years (range 20-97) and 58 year (range 21 – 94), triple negative tumors accounted for 20% and 19% of cases, and median follow-up reached 26 months and 22 months respectively.
Table reports median OS and PFS, according to lines and type of chemotherapy.
OS eribulin (months)OS other chemotherapy (months)pPFS Eribulin (months)PFS other chemotherapy (months)pSecond line12.4 (11.3-15.1)11.8 (11.3-12.3)0.4654.1 (3.7-4.9)4.1 (4.0-4.3)0.9225Third line10.3 (9.3-11.5)7.7 (7.3-8.0)<.00013.6 (3.2-3.9)3.0 (2.9-3.2)0.0058
Supportive analyses (using a propensity score for adjustment and as a matching factor for nested case–control analyses) and sensitivity analyses will be available for full presentation at the meeting.
Conclusion: In this large-scale real-life setting, MBC patients treated with third line eribulin showed an improved OS and PFS compared with those receiving another chemotherapy. The difference was not statistically significant for second line treatment.
Citation Format: Jacot W, Heudel P-E, Fraisse J, Gourgou S, Guiu S, Dalenc F, Pistilli B, Campone M, Levy C, Debled M, Leheurteur M, Chaix M, Lefeuvre C, Goncalves A, Uwer L, Ferrero J-M, Eymard J-C, Petit T, Mouret-Reynier M-A, Courtinard C, Cottu P, Robain M, Mailliez A. Real-life activity of eribulin among metastatic breast cancer patients in the multicenter national observational ESME program [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P6-14-02.
Collapse
Affiliation(s)
- W Jacot
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - P-E Heudel
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - J Fraisse
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - S Gourgou
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - S Guiu
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - F Dalenc
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - B Pistilli
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - M Campone
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - C Levy
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - M Debled
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - M Leheurteur
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - M Chaix
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - C Lefeuvre
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - A Goncalves
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - L Uwer
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - J-M Ferrero
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - J-C Eymard
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - T Petit
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - M-A Mouret-Reynier
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - C Courtinard
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - P Cottu
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - M Robain
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| | - A Mailliez
- Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, France; Centre Léon Bérard, Lyon, France; IUCT Oncopole, Toulouse, France; Gustave Roussy, Villejuif, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre François-Baclesse, Caen, France; Institut Bergonié, Bordeaux, France; Centre Henri Becquerel, Rouen, France; Centre Georges Francois Leclerc, Dijon, France; Centre Eugène Marquis, Rennes, France; Institut Paoli-Calmettes, Marseille, France; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Centre Antoine Lacassagne, Nice, France; Institut de Cancérologie Jean Godinot, Reims, France; Centre Paul Strauss, Strasbourg, France; Centre Jean-Perrin, Clermont-Ferrand, France; UNICANCER, Paris, France; Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France
| |
Collapse
|